[ad_1]
An anti-Covid vaccine jointly developed by Pfizer and BioNTech found to be effective in preventing 90 percent of infections during phase 3 of the trial, which is still ongoing. This was announced by the president of Pfizer, Albert Bourla.
Germany’s Biontech confirms Pfizer’s announcement, announcing in a publication that it intends to request authorization for production, together with Pfizer itself, next week from the US FDA.
“Today’s news about the virus vaccine is encouraging. But we still need a lot of caution. Scientific research is the real key to overcoming the emergency. Meanwhile, we must never forget that the behavior of each of us is essential to turn the curve. “. . This was stated by the Minister of Health Roberto Speranza on Fb.
Today’s news about the coronavirus vaccine is encouraging. But much caution is still needed. Scientific research is the real key to overcoming the emergency.
Meanwhile, we must not forget that the behaviors of each one of us are essential to round the curve.– Roberto Speranza (@robersperanza) November 9, 2020
Euphoria in the markets on news of an upcoming vaccine from Pfizer and BioNTech.
“We want to act in a European way and not following a national line.” This was stated by the German Health Minister, Jens Spahn, at a press conference in Berlin, commenting on the news of the publication of the data from Biontech, which is preparing to request an authorization for the vaccine, capable of protecting by 90 % of the virus. “We have to come up with a voluntary vaccine,” Spahn reiterated as well. “When asked what dosage amounts and when will they be available, we are still unable to answer,” he added.
“At present, it is likely that a vaccine against a new virus can be achieved as quickly as never before in human history,” said Jens Spahn, commenting on data published by Biontech and Pfizer. “We can be optimistic,” he added.
The Covid vaccine gives “hope”, but the battle is still long. This is what US President-elect Joe Biden says.
The effectiveness of the Pfizer vaccine is “extraordinary”: will have a major impact on the response to Covid-19. This was stated by Anthony Fauci, the American super expert on infectious diseases.
“Good news from Pfizer and BioNTech on the positive results of their clinical trial for a Covid-19 vaccine. European science works! The Commission will soon sign a contract with them for up to 300 million doses. We continue to protect each other. so much”, writes the President of the European Commission, Ursula von der Leyen, on Twitter.
“Encouraging News”. This is how WHO Director General Tedros Adhanom Ghebreyesus comments on Pfizer’s announcement.
[ad_2]
